AgeX Therapeutics, Inc.
AgeX Therapeutics, Inc. (AGE) Stock Overview
Explore AgeX Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
27.8M
P/E Ratio
-6.11
EPS (TTM)
$-482.53
ROE
7.50%
AGE Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of AgeX Therapeutics, Inc. (AGE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $9.25.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.11 and a market capitalization of 27.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.